contact
Committed to transforming
the treatment of severe, chronic
autoimmune diseases.
About us
Technology
Pipeline
Business development
Careers
News & Events
Contact
contact
Menu
Committed to transforming
the treatment of severe, chronic
autoimmune diseases.
About us
Technology
Pipeline
Business development
Careers
News & Events
Contact
News
2019-09-12
Imcyse to present positive results in EAE model of multiple sclerosis at ECTRIMS 2019
Read more
2019-08-27
Imcyse reports successful first-in-human phase 1B study in type 1 diabetes with IMCY-0098
Read more
2019-08-05
Imcyse announces changes in management and board, appoints Thomas Taapken as Executive Chairman
Read more
2019-06-18
Imcyse secures total of €35M in Series B financing round and additional grants
Read more
1
2
3
4
Go Back